Estonia

Methadone/Buprenorphine Treatment: available

There are three substitution treatment facilities in Estonia. Foreign methadone and buprenorphine patients will be accepted for temporary treatment, provided their home prescribers contact one of these clinics well in advance of the expected date of their patients' arrival. Up-to-date information is available via the Central and Eastern European Harm Reduction Network.

Importation of Methadone, Buprenorphine, Codeine, Morphine: possible

It is allowed to bring into Estonia methadone, buprenorphine and other opioids in quantities needed for up to one week's treatment (seven daily doses) without a permit of the State Agency of Medicines (Ravimiamet). Patients have to carry with them a letter from their prescribing GP or clinic clearly stating the need for the medication.

If the quantity of methadone or other opioids intented to be brought into Estonia exceeds seven daily doses the prescribing GPs or clinics must apply for an import permit at the State Agency of Medicines (Ravimiamet) on behalf of their patients (see contact details below).

Contact Addresses:

Treatment facilities

Rehabilitation Centre for Drug and Alcohol Dependent
Karja 6
Narva
Phone/fax: +372 35 48 344

AIDS Information and Support Center
Kopli 32
Tallinn
Phone/fax: +372 6 413165

Dependence Centre of West-Tallinn Central Hospital
Sole 63
Tallinn
Phone: +372 66 65216
Fax: +372 66 65212


Others

Central and Eastern European Harm Reduction Network
Phone: +370 52691600
Email
Web Site

Ravimiamet (State Agency of Medicines)
Nooruse 1
50411 Tartu
Estonia
Web Site

Latest news on customs regulations: Maksu- ja Tolliamet (Estonian Tax and Customs Board)
Web Site

Any comments and additional information greatly appreciated.
Please address all correspondence to:

Ralf Gerlach
INDRO e.V.
Bremer Platz 18-20
48155 Münster
Germany
Phone: +49 2571-582765 or +49 251-60123
Fax: +49 2571-584868 or +49 251-666580
Email: INDROeV@t-online.de


Back to travel guide index

(This page last revised and updated July 3, 2006)